Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug launch
Pharma
J&J's Imaavy wins FDA green light in myasthenia gravis
The FDA on Wednesday approved J&J’s nipocalimab under the brand name Imaavy as a new treatment for generalized myasthenia gravis.
Fraiser Kansteiner
Apr 30, 2025 10:51am
Novartis builds momentum with new drug launches
Apr 29, 2025 10:52am
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
Apr 10, 2025 10:00am
Alnylam's Amvuttra wins key cardiomyopathy FDA nod
Mar 20, 2025 7:40pm
Akebia sketches out pivotal Vafseo study in nondialysis patients
Mar 13, 2025 3:28pm
Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis
Mar 12, 2025 2:13pm
.jpg?VersionId=rKfXgG6zD0qa2yVWv55s6YEJujkOSVMg)